Perioperative blood transfusion in radical cystectomy: Analysis of the National Surgical Quality Improvement Program database

International Journal of Urology

Volumn 23, Issue 9, 2016, Pages 745-750

  Sui, Wilson ^a   Onyeji, Ifeanyi C ^a   Matulay, Justin T ^a   James, Maxwell B ^a   Theofanides, Marissa C ^a   Wenske, Sven ^a   DeCastro, Guarionex J ^a  

^a Department of Orthopaedic Surgery   (United States)

Author keywords

bladder cancer; blood transfusions; complications; cystectomy; perioperative care

Indexed keywords

ANTINEOPLASTIC AGENT;

ACUTE KIDNEY FAILURE; AGE; AGED; ARTICLE; ASCITES; BLADDER CANCER; BLEEDING; BLOOD TRANSFUSION; BODY MASS; CANCER CHEMOTHERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CEREBROVASCULAR ACCIDENT; COMA; COMORBIDITY; CONTROLLED STUDY; CURRENT PROCEDURAL TERMINOLOGY; CYSTECTOMY; DEEP VEIN THROMBOSIS; FEMALE; GRAFT FAILURE; HEART ARREST; HEART INFARCTION; HOSPITAL READMISSION; HUMAN; KIDNEY FAILURE; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MORBIDITY; MULTIMODALITY CANCER THERAPY; OPERATION DURATION; PERIOPERATIVE BLOOD TRANSFUSION; PERIOPERATIVE PERIOD; PERIPHERAL NERVE INJURY; PEROPERATIVE COMPLICATION; PNEUMONIA; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; PROSTHESIS FAILURE; RESUSCITATION; RETROSPECTIVE STUDY; RISK FACTOR; SEPTIC SHOCK; SEX; SMOKING; SURGICAL INFECTION; SURGICAL MORTALITY; SURGICAL RISK; TREATMENT OUTCOME; URINARY TRACT INFECTION; WOUND DEHISCENCE;

EID: 84985006668     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.13152     Document Type: Article

References (30)

1. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J. Clin. 2015; 65: 5–29.
2. Novotny V, Hakenberg OW, Wiessner D et al. Perioperative complications of radical cystectomy in a contemporary series. Eur. Urol. 2007; 51: 397–401.
3. Patel HD, Ball MW, Cohen JE, Kates M, Pierorazio PM, Allaf ME. Morbidity of urologic surgical procedures: an analysis of rates, risk factors, and outcomes. Urology 2015; 85: 552–9.
4. Gandaglia G, Varda B, Sood A et al. Short-term perioperative outcomes of patients treated with radical cystectomy for bladder cancer included in the National Surgical Quality Improvement Program (NSQIP) database. Can. Urol. Assoc. J. 2014; 8: E681–7.
5. Chang SS, Smith JA Jr, Wells N, Peterson M, Kovach B, Cookson MS. Estimated blood loss and transfusion requirements of radical cystectomy. J. Urol. 2001; 166: 2151–4.
6. Hollenbeck BK, Miller DC, Taub D et al. Identifying risk factors for potentially avoidable complications following radical cystectomy. J. Urol. 2005; 174 (4 Pt 1): 1231–7.
7. Konety BR, Allareddy V, Herr H. Complications after radical cystectomy: analysis of population-based data. Urology 2006; 68: 58–64.
8. Shabsigh A, Korets R, Vora KC et al. Defining early morbidity of radical cystectomy for patients with bladder cancer using a standardized reporting methodology. Eur. Urol. 2009; 55: 164–74.
9. Morgan TM, Barocas DA, Chang SS et al. The relationship between perioperative blood transfusion and overall mortality in patients undergoing radical cystectomy for bladder cancer. Urol Oncol. 2013; 31: 871–7.
10. Linder BJ, Frank I, Cheville JC et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur. Urol. 2013; 63: 839–45.
11. Opelz G, Mickey MR, Terasaki PI. Blood transfusions and unresponsiveness to HL-A. Transplantation 1973; 16: 649–54.
12. Komatsu Y, Orita H, Sakurada M, Maekawa H, Hoppo T, Sato K. Intraoperative blood transfusion contributes to decreased long-term survival of patients with esophageal cancer. World J. Surg. 2012; 36: 844–50.
13. Halabi WJ, Jafari MD, Nguyen VQ et al. Blood transfusions in colorectal cancer surgery: incidence, outcomes, and predictive factors: an American College of Surgeons National Surgical Quality Improvement Program analysis. Am. J. Surg. 2013; 206: 1024–32.
14. Bernard AC, Davenport DL, Chang PK, Vaughan TB, Zwischenberger JB. Intraoperative transfusion of 1 U to 2 U packed red blood cells is associated with increased 30-day mortality, surgical-site infection, pneumonia, and sepsis in general surgery patients. J. Am. Coll. Surg. 2009; 208: 931–7, 937.e1-2.
15. Daley J, Khuri SF, Henderson W et al. Risk adjustment of the postoperative morbidity rate for the comparative assessment of the quality of surgical care: results of the National Veterans Affairs Surgical Risk Study. J. Am. Coll. Surg. 1997; 185: 328–40.
16. Shiloach M, Frencher SK Jr, Steeger JE et al. Toward robust information: data quality and inter-rater reliability in the American College of Surgeons National Surgical Quality Improvement Program. J. Am. Coll. Surg. 2010; 210: 6–16.
17. Kluth LA, Xylinas E, Rieken M et al. Impact of peri-operative blood transfusion on the outcomes of patients undergoing radical cystectomy for urothelial carcinoma of the bladder. BJU Int. 2014; 113: 393–8.
18. Jahnson S, Bergstrom R, Pedersen J. Extent of blood transfusion and cancer-related mortality after cystectomy and urinary diversion for bladder cancer. Br. J. Urol. 1994; 74: 779–84.
19. Soubra A, Zabell JR, Adejoro O, Konety BR. Effect of perioperative blood transfusion on mortality for major urologic malignancies. Clin. Genitourin. Cancer 2015; 13: e173–81.
20. Wang YL, Jiang B, Yin FF et al. Perioperative blood transfusion promotes worse outcomes of bladder cancer after radical cystectomy: a systematic review and meta-analysis. PLoS ONE 2015; 10: e0130122.
21. Blumberg N, Heal JM. Effects of transfusion on immune function. Cancer recurrence and infection. Arch. Pathol. Lab. Med. 1994; 118: 371–9.
22. Upile T, Jerjes W, Mahil J, Sudhoff H, Hopper C, Wright A. Blood product transfusion and cancer prognosis. Clin. Adv. Hematol. Oncol. 2009; 7: 656–61.
23. Jensen LS, Hokland M, Nielsen HJ. A randomized controlled study of the effect of bedside leucocyte depletion on the immunosuppressive effect of whole blood transfusion in patients undergoing elective colorectal surgery. Br. J. Surg. 1996; 83: 973–7.
24. Hebert PC, Wells G, Blajchman MA et al. A multicenter, randomized, controlled clinical trial of transfusion requirements in critical care. Transfusion Requirements in Critical Care Investigators, Canadian Critical Care Trials Group. N. Engl. J. Med. 1999; 340: 409–17.
25. Walsh TS, Boyd JA, Watson D et al. Restrictive versus liberal transfusion strategies for older mechanically ventilated critically ill patients: a randomized pilot trial. Crit. Care Med. 2013; 41: 2354–63.
26. Cooper HA, Rao SV, Greenberg MD et al. Conservative versus liberal red cell transfusion in acute myocardial infarction (the CRIT Randomized Pilot Study). Am. J. Cardiol. 2011; 108: 1108–11.
27. Prescott LS, Aloia TA, Brown AJ et al. Perioperative blood transfusion in gynecologic oncology surgery: analysis of the National Surgical Quality Improvement Program Database. Gynecol. Oncol. 2015; 136: 65–70.
28. Venkat R, Guerrero MA. Risk factors and outcomes of blood transfusions in adrenalectomy. J. Surg. Res. 2015; 199: 505–11.
29. Duffy G, Neal KR. Differences in post-operative infection rates between patients receiving autologous and allogeneic blood transfusion: a meta-analysis of published randomized and nonrandomized studies. Transfus. Med. 1996; 6: 325–8.
30. Abel EJ, Linder BJ, Bauman TM et al. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur. Urol. 2014; 66: 1139–47.